Christopher J Gregory

Datos Biográficos

ID7007915
NOMBREChristopher J Gregory
NOMBRESChristopher J
APELLIDOGregory
FIRMAGREGORY C J
AFILIACIONESCenters for Disease Control and Prevention
VERIFICADONo
TOTAL DE OBRAS7
TOTAL DE CITAS0
TOTAL COMO AUTOR7
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2019
AÑO MÁS RECIENTE DE PUBLICACIÓN2022
ÍNDICE H0

  • Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella

    Open AccessMateusz Hasso-Agopsowicz, Natasha S Crowcroft et al.ARTICLEFrontiers in Public Health2022

    Measles and rubella microarray patches (MR-MAPs) are critical in achieving measles and rubella eradication, a goal highly unlikely to meet with current vaccines presentations. With low commercial incentive to MAP developers, limited and uncertain funding, the need for investment in a novel manufacturing facility, and remaining questions about the source of antigen, product demand, and regulatory pathway, MR-MAPs are unlikely to be prequalified by…

  • Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm

    Open AccessHelena Martin, H Martı́n et al.ARTICLEJournal of Global Health2022

    Background: The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old. We aimed to collate an individual patient-level data set from large, high-quality pre-existing studies on pneumonia in children to identify a set of signs and symptoms with greater validity in the diagnosis, prognosis, and possible trea…

  • Improving community coverage of Japanese encephalitis vaccination

    Open AccessMichael C Thigpen, Svay Sarath et al.ARTICLEBMC Public Health2022

    A mass Japanese encephalitis (JE) immunization campaign for children aged 9 months through 12 years was conducted in 2013 in Battambang province, western Cambodia. Vaccinators working at almost 2,000 immunization posts in approximately 800 villages provided vaccinations to almost 310,000 children using one dose of Chengdu Institute of Biological Products' live, attenuated SA14-14-2 JE vaccine (CD-JEV), achieving a coverage rate of greater than 90…

  • Rethinking public health campaigns in the Covid-19 era

    Open AccessHamid Jafari, Kristin N Saarlas et al.ARTICLEBMJ Global Health2021

  • Performance of existing and novel surveillance case definitions for Covid-19 in household contacts of PCR-confirmed Covid-19

    Open AccessHannah E Reses, Mark Fajans et al.ARTICLEBMC Public Health2021

    Existing COVID-19 case definitions appropriately screened in household contacts with COVID-19. Novel symptom combinations incorporating taste or smell dysfunction as a primary component improved accuracy. Case definitions tailored for children versus adults should be further explored

  • Enhanced surveillance for severe pneumonia, Thailand 2010–2015

    Open AccessCharatdao Bunthi, Henry C Baggett et al.ARTICLEBMC Public Health2019

    Enhanced surveillance improved the understanding of the etiology of severe pneumonia cases and improved the MOPH's preparedness and response capacity for emerging respiratory pathogens in Thailand thereby enhanced global health security. Guidelines for investigation of severe pneumonia from this project were incorporated into surveillance and research activities within Thailand and shared for adaption by other countries

  • Population-based bloodstream infection surveillance in rural Thailand, 2007–2014

    Open AccessJulia Rhodes, Possawat Jorakate et al.ARTICLEBMC Public Health2019

    Population-based surveillance documented CO BSI incidence estimates higher than previously reported from Thailand and the region, with temporal increases seen in older populations. The most commonly observed pathogens including resistance profiles were similar to leading pathogens and resistance profiles worldwide, thus; prevention strategies with demonstrated success elsewhere may prove effective in Thailand